Replies to post #459154 on Anavex Life Sciences Corp (AVXL)

[tredenwater2]

The same I think about Anavex and their Alzheimer’s future SOC drug which has 35,000,000 patients globally. We arrrrrrrGrrrrreatttt !!!!!!!

If we get 10% penetration, upon approval, of each in the first 6 months of rollout and then 15-20% every quarter until 2/3 to 3/4 (3-4 years upon approval) of the patients are on our drug we will blow by any revenue estimates posted/listed here.

Obviously independence is a must and with prophylactic use, profits and royalties and puts us in the JNJ size and more with a comfortably conservative PE of only10-15.

I can wait, patients has been a virtue for 10 years now, whats another 2-4 years?

Tred